Published in Breast Cancer Res Treat on October 24, 2007
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat (2010) 1.29
Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res (2008) 1.09
Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv (2009) 0.91
Breast cancer screening beliefs among older Korean American women. J Gerontol Nurs (2009) 0.82
An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures. Cancer Epidemiol Biomarkers Prev (2012) 0.79
Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes? BMC Health Serv Res (2011) 0.78
A comparison of breast and cervical cancer legislation and screening in Georgia, North Carolina, and South Carolina. J Health Care Poor Underserved (2012) 0.75
Local recurrence of breast cancer 52 years after halsted mastectomy: is there a role for more aggressive ipsilateral surveillance? Case Rep Oncol Med (2011) 0.75
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med (2016) 0.75
Association between hormone receptors and HER-2/neu is age-related. Int J Clin Exp Pathol (2015) 0.75
Practices that reduce the Latina survival disparity after breast cancer. J Womens Health (Larchmt) (2013) 0.75
Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer. Br J Cancer (2017) 0.75
Annual surveillance mammography after early-stage breast cancer and breast cancer mortality. Curr Oncol (2016) 0.75
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
Characteristics and career intentions of the emerging MD/PhD workforce. JAMA (2008) 5.96
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep (2013) 3.85
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res (2004) 2.78
Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol (2007) 2.36
Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg (2009) 2.14
The Chiari Severity Index: a preoperative grading system for Chiari malformation type 1. Neurosurgery (2015) 1.86
Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology (2010) 1.86
Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol (2009) 1.75
Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol (2007) 1.66
Risk factors for surgical site infection after major breast operation. J Am Coll Surg (2008) 1.66
Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg (2007) 1.65
Evaluation of clinical research training programs using the clinical research appraisal inventory. Clin Transl Sci (2010) 1.57
Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause (2010) 1.56
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother (2012) 1.55
Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Ann Surg Oncol (2008) 1.55
Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis. Oncologist (2013) 1.54
Characteristics of medical school matriculants who participated in postbaccalaureate premedical programs. Acad Med (2011) 1.53
Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res (2012) 1.53
Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data. J Clin Epidemiol (2005) 1.52
Predictors of primary breast abscesses and recurrence. World J Surg (2009) 1.51
Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health (2006) 1.49
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res (2007) 1.45
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J Immunother (2007) 1.45
Neighborhood socioeconomic deprivation and mortality: NIH-AARP diet and health study. PLoS One (2010) 1.44
Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat (2010) 1.41
Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data. J Surg Res (2009) 1.39
Variables associated with full-time faculty appointment among contemporary U.S. Medical school graduates: implications for academic medicine workforce diversity. Acad Med (2010) 1.39
Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health (2011) 1.39
Certification by the American Board of Surgery among US medical school graduates. J Am Coll Surg (2012) 1.38
Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. J Immunol (2002) 1.37
Patient concerns about medical errors in emergency departments. Acad Emerg Med (2005) 1.32
A survey of Internet utilization among patients with cancer. Support Care Cancer (2010) 1.32
Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J Immunol (2003) 1.32
Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res (2009) 1.30
The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol (2008) 1.28
Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer (2012) 1.27
Safe medication prescribing: training and experience of medical students and housestaff at a large teaching hospital. Acad Med (2005) 1.27
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. Cancer Discov (2014) 1.26
Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control (2003) 1.24
Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J Immunother (2005) 1.22
Photoacoustic microscopy of tyrosinase reporter gene in vivo. J Biomed Opt (2011) 1.21
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res (2005) 1.21
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn (2003) 1.20
Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol (2010) 1.19
The road to an academic medicine career: a national cohort study of male and female U.S. medical graduates. Acad Med (2012) 1.19
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol (2010) 1.18
Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer. Am J Surg (2009) 1.16
Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J Biol Chem (2004) 1.15
Area-level poverty and preterm birth risk: a population-based multilevel analysis. BMC Public Health (2008) 1.15
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer (2007) 1.12
Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005. Breast Cancer Res Treat (2010) 1.12
Breast cancer screening and incidence in communities with a high proportion of uninsured. Am J Prev Med (2007) 1.11
Geographic clustering of adequate diagnostic follow-up after abnormal screening results for breast cancer among low-income women in Missouri. Ann Epidemiol (2007) 1.10
Adherence to nasal positive airway pressure therapy among school-aged children and adolescents with obstructive sleep apnea syndrome. Pediatrics (2007) 1.10
Outcomes evaluation of the 2005 National Pediatric Emergency Medicine Fellows' Conference. Pediatr Emerg Care (2008) 1.09
Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res (2008) 1.09
Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol (2010) 1.08
What predicts USMLE Step 3 performance? Acad Med (2005) 1.08
Patients' concerns about medical errors during hospitalization. Jt Comm J Qual Patient Saf (2007) 1.08
Treatment and outcomes of patients with primary breast sarcoma. Am J Surg (2008) 1.07
What predicts surgical internship performance? Am J Surg (2004) 1.07
Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005. Cancer Epidemiol Biomarkers Prev (2010) 1.06
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res (2006) 1.02
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2011) 1.02
Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer (2009) 1.00
"Making the grade:" noncognitive predictors of medical students' clinical clerkship grades. J Natl Med Assoc (2007) 1.00
A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat (2010) 1.00
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth. J Clin Invest (2014) 1.00
Identifying factors associated with disability-related differences in breast cancer screening (United States). Cancer Causes Control (2003) 0.99
Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg (2008) 0.99
Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg (2010) 0.98
The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat (2004) 0.97
Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction. Am J Surg (2007) 0.97
Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response. Ann Surg Oncol (2011) 0.97